IND-SWIFT
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Ind-Swift along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.14₹ 0.77
As on Aug 13, 2025, 4:01 PM IST
Ind-Swift Price Performance
Today's LowToday's High
₹14.86₹17.82
₹15.75
52 Weeks' Low52 Weeks' High
₹12.00₹34.49
₹15.75
Open Price
₹14.86
Prev. Close
₹14.98
Volume
97,760
Over the last 5 years, the share price of Ind-Swift has gained 40.27% CAGR. Over the past year, the corresponding return has been -33.54%.
Ind-Swift’s current P/E of 0.30x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Ind-Swift Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ind-Swift | 5.14 | -11.07 | 4.44 | 12.82 | -33.54 | 16.62 | 40.27 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Ind-Swift has declined 33.54% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Ind-Swift has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Ind-Swift Financials
Ind-Swift Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 15.34 | 15.5 |
| 10 | 15.89 | 15.81 |
| 20 | 16.54 | 16.25 |
| 50 | 16.91 | 16.41 |
| 100 | 15.43 | 16.58 |
| 200 | 18.44 | 17.6 |
Ind-Swift Share Holding Pattern
In the latest quarter, Ind-Swift remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 44.42% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Ind-Swift Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 01, 2025, 12:28 AM IST | Ind-Swift L - Announcement Of Record Date Under Regulation 42 Of SEBI (LODR) Regulation, 2015 |
| Aug 01, 2025, 12:24 AM IST | Ind-Swift L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Jul 29, 2025, 10:10 PM IST | Ind-Swift L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Jul 23, 2025, 12:34 AM IST | Ind-Swift L - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| Jul 18, 2025, 12:44 AM IST | Ind-Swift L - Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
About Ind-Swift
Ind-Swift Ltd. is a Public Limited Listed company incorporated on 06/06/1986 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24230CH1986PLC006897 and registration number is 006897. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 515.23 Cr. and Equity Capital is Rs. 10.83 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address781, Industrial Area, Phase II Chandigarh Chandigarh 160002
- Contact
Management
- Mr. S R MehtaExecutive Chairman
- Mr. N R MunjalNon Executive Director
- Dr. Gopal MunjalManaging Director & CEO
- Dr. V R MehtaJoint Managing Director
- Mr. Himanshu JainNon Executive Director
- Mr. Rishav MehtaNon Executive Director
- Mr. S P SharmaIndependent Director
- Dr. V K AroraIndependent Director
- Mr. S C GalhotraIndependent Director
- Ms. Anoop MichraIndependent Director
- Mr. Jagvir Singh AhluwaliaIndependent Director
- Mr. Bhupinder SinghIndependent Director
- Mr. Subodh GuptaIndependent Director
- Mr. Prabhat KhuranaIndependent Director
FAQs on Ind-Swift Share Price
What is the share price of Ind-Swift?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ind-Swift is ₹15.75 as on Aug 13, 2025.
What kind of stock is Ind-Swift?
The Ind-Swift is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Ind-Swift?
The market cap of Ind-Swift is ₹85.31 Cr as on Aug 13, 2025.
What are today's High and Low prices of Ind-Swift?
Today’s highest and lowest price of Ind-Swift are ₹17.82 and ₹14.86.
What are the 52 Week High and 52 Week Low of Ind-Swift?
The 52-week high/low is the highest and lowest price at which Ind-Swift stock has traded in the past 52-week or nearly a year. The 52-week high of Ind-Swift is ₹34.49 and 52-week low of Ind-Swift is ₹12.00 as on Aug 13, 2025.
How has the Ind-Swift performed historically in terms of returns?
The Ind-Swift has shown returns of 5.14% over the past day, -11.07% for the past month, 4.44% over 3 months, -33.54% over 1 year, 16.62% across 3 years, and 40.27% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Ind-Swift?
P/E ratio of and PB ratio of Ind-Swift are 0.30 and -0.21 on Aug 13, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse